The DOI matches its Crossref record; 474 of the 474 references it cites were found in a registry or an index.
Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 474
Cyclic AMP-Dependent Kinase Regulates Raf-1 Kinase Mainly by Phosphorylation of Serine 259
Dhillon, A. S., Pollock, C., Steen, H., Shaw, P. E., Mischak, H., & Kolch, W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3237-3246.2002 · Cited by 230
MafB, a new Maf family transcription activator that can associate with Maf and Fos but not with Jun.
Kataoka, K., Fujiwara, K. T., Noda, M., & Nishizawa, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7581 · Cited by 230
Pérez-Roger, I., Solomon, D. L., Sewing, A., & Land, H. (1997) · Oncogene · doi:10.1038/sj.onc.1201197 · Cited by 230
Antisense therapy in oncology: new hope for an old idea?
Tamm, I., Dörken, B., & Hartmann, G. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05629-x · Cited by 229
Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo.
Pulverer, B., Fisher, C., Vousden, K. H., Littlewood, T. D., Evan, G. I., & Woodgett, J. R. (1994) · PubMed · Cited by 228
Daksis, J. I., Lu, R. Y., Facchini, L. M., Marhin, W. W., & Penn, L. Z. (1994) · PubMed · Cited by 227
Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers.
Berberich, S. J., & Cole, M. D. (1992) · Genes & Development · doi:10.1101/gad.6.2.166 · Cited by 225
Ikappa Balpha is a target for the mitogen-activated 90kDa ribosomal S6 kinase
Schouten, G. J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.3133 · Cited by 225
Seth, A., Alvarez, E., Gupta, S., & Davis, R. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54312-x · Cited by 225
Pritchard, C. A., Samuels, M. L., Bosch, E., & McMahon, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.6430 · Cited by 224
Cooperating oncogenes converge to regulate cyclin/cdk complexes.
Lloyd, A. C., Obermüller, F., Staddon, S., Barth, C. F., McMahon, M., & Land, H. (1997) · Genes & Development · doi:10.1101/gad.11.5.663 · Cited by 224
Nemoto, S., DiDonato, J. A., & Lin, A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7336 · Cited by 224
Raf-1-associated Protein Phosphatase 2A as a Positive Regulator of Kinase Activation
Abraham, D., Podar, K., Pacher, M., Kubicek, M., Welzel, N., Hemmings, B. A., Dilworth, S. M., Mischak, H., Kolch, W., & Baccarini, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003259200 · Cited by 219
Net, a new ets transcription factor that is activated by Ras.
Giovane, A., Pintzas, A., Maira, S. M., Sobieszczuk, P., & Wasylyk, B. (1994) · Genes & Development · doi:10.1101/gad.8.13.1502 · Cited by 219
Xia, Z., Tan, M., Wei-Lynn Wong, W., Dimitroulakos, J., Minden, M., & Penn, L. (2001) · Leukemia · doi:10.1038/sj.leu.2402196 · Cited by 218
Cyclin G Recruits PP2A to Dephosphorylate Mdm2
Okamoto, K., Li, H., Jensen, M. R., Zhang, T., Taya, Y., Thorgeirsson, S. S., & Prives, C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00504-x · Cited by 215
Histone deacetylase as a new target for cancer chemotherapy
Yoshida, M., Furumai, R., Nishiyama, M., Komatsu, Y., Nishino, N., & Horinouchi, S. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100300 · Cited by 215
Inhibitors of Histone Deacetylase as New Anticancer Agents
Jung, M. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372058 · Cited by 213
Sun, J., Blaskovich, M. A., Knowles, D. B., Qian, Y., Ohkanda, J., Bailey, R. D., Hamilton, A. D., & Sebti, S. M. (1999) · PubMed · Cited by 213
Transformation by ras modifies AP1 composition and activity
Mechta, F., Lallemand, D., Pfarr, C. M., & Yaniv, M. (1997) · Oncogene · doi:10.1038/sj.onc.1200900 · Cited by 212
Mice Lacking the ERK1 Isoform of MAP Kinase Are Unimpaired in Emotional Learning
Selcher, J. C., Nekrasova, T., Paylor, R., Landreth, G. E., & Sweatt, J. D. (2001) · Learning & Memory · doi:10.1101/lm.37001 · Cited by 211
Dnmt3L is a transcriptional repressor that recruits histone deacetylase
Deplus, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf509 · Cited by 210
CREB is activated by UVC through a p38/HOG-1-dependent protein kinase
Iordanov, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.5.1009 · Cited by 210
Participation of cyclin A in Myc-induced apoptosis.
Hoang, A. T., Cohen, K. J., Barrett, J. F., Bergstrom, D. A., & Dang, C. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.6875 · Cited by 206
Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine)
Sato, S., Fujita, N., & Tsuruo, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205225 · Cited by 206
Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation
Jin, S., Gorfajn, B., Faircloth, G., & Scotto, K. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6775 · Cited by 206
Serine/threonine phosphorylation in cytokine signal transduction
McCubrey, J., May, W. S., Duronio, V, & Mufson, A. (2000) · Leukemia · doi:10.1038/sj.leu.2401657 · Cited by 206
Self-citationGhoda, L., Lin, X., & Greene, W. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21281 · Cited by 204
Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C
Chilov, D., Kukk, E., Taira, S., Jeltsch, M., Kaukonen, J., Palotie, A., Joukov, V., & Alitalo, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25176 · Cited by 204
Diaz, B., Barnard, D., Filson, A., MacDonald, S., King, A., & Marshall, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4509 · Cited by 203
Schreck, R., & Baeuerle, P. A. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.3.1281 · Cited by 202
Pugazhenthi, S., Miller, E., Sable, C., Young, P., Heidenreich, K. A., Boxer, L. M., & Reusch, J. E.-B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27529 · Cited by 199
ITAZAKI, H., NAGASHIMA, K., SUGITA, K., YOSHIDA, H., KAWAMURA, Y., YASUDA, Y., MATSUMOTO, K., ISHII, K., UOTANI, N., NAKAI, H., et al. (1990) · The Journal of Antibiotics · doi:10.7164/antibiotics.43.1524 · Cited by 197
Expression of raf family proto-oncogenes in normal mouse tissues.
Sm, S., Jl, C., & Rapp, U. R. (1990) · PubMed · Cited by 196
Loda, M. F., Capodieci, P., Mishra, R., Yao, H. W., Corless, C. L., Grigioni, W. F., Wang, Y., Magi-Galluzzi, C., & Stork, P. A. (1996) · Europe PMC (PubMed Central) · Cited by 195
RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)
Flotho, C., Valcamonica, S., Mach-Pascual, S., Schmahl, G., Corral, L., Ritterbach, J., Hasle, H., Aricò, M., Biondi, A., & Niemeyer, C. (1999) · Leukemia · doi:10.1038/sj.leu.2401240 · Cited by 194
Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression
O'Hagan, R. C., Ohh, M., David, G., de Alboran, I. M., Alt, F. W., Kaelin, W. G., & DePinho, R. A. (2000) · Genes & Development · doi:10.1101/gad.827200 · Cited by 194
McCarthy, S. A., Samuels, M. L., Pritchard, C. A., Abraham, J. A., & McMahon, M. (1995) · Genes & Development · doi:10.1101/gad.9.16.1953 · Cited by 193
Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
Kerppola, T. K., & Curran, T. (1994) · PubMed · Cited by 193
Ellis, C. A., & Clark, G. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(00)00084-x · Cited by 192
Cellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b
Malumbres, M., de Castro, I. P., Hernández, M. I., Jiménez, M., Corral, T., & Pellicer, À. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2915-2925.2000 · Cited by 191
Kim, S., Li, Q., Dang, C. V., & Lee, L. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200372597 · Cited by 188
Xu, S., Robbins, D. J., Frost, J. A., Dang, A., Lange, C. A., & Cobb, M. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6808 · Cited by 186
Protein kinase C inhibitors as novel anticancer drugs
Jirousek, M. R., & Goekjian, P. G. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.12.2117 · Cited by 182
c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.
Reisman, D., Elkind, N. B., Roy, B., Beamon, J., & Rotter, V. (1993) · PubMed · Cited by 182
Ras caught in another affair: the exchange factors for Ral
Wolthuis, R. M. F., & Bos, J. L. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80016-1 · Cited by 180
Baudino, T. A., & Cleveland, J. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.691-702.2001 · Cited by 179
Matsui, K., Fine, A., Zhu, B., Marshak‐Rothstein, A., & Ju, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3469 · Cited by 178
Raf induces NF-κB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation
Baumann, B., Weber, C. K., Troppmair, J., Whiteside, S., Israel, A., Rapp, U. R., & Wirth, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080583397 · Cited by 177
Jung, M., Brosch, G., Kölle, D., Scherf, H., Gerhäuser, C., & Loidl, P. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm991091h · Cited by 176
Regulatory Role of MEF2D in Serum Induction of the c-jun Promoter
Han, T.-H., & Prywes, R. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.2907 · Cited by 173
The MEK Pathway Is Required for Stimulation of p21WAF1/CIP1 by Transforming Growth Factor-β
Hu, P. P.-C., Shen, X., Huang, D., Liu, Y. I., Counter, C. M., & Wang, X.-F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35381 · Cited by 172
Sgambato, V., Vanhoutte, P., Pagès, C., Rogard, M., Hipskind, R. A., Besson, M., & Caboche, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00214.1998 · Cited by 171
Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis
Kwon, H. J., Kim, M. S., Kim, M. J., Nakajima, H., & Kim, K. (2002) · International Journal of Cancer · doi:10.1002/ijc.1602 · Cited by 171
Identification of p90RSK as the probable CREB-Ser133 kinase in human melanocytes.
Böhm, M., Moellmann, G. E., Cheng, E., Alvarez‐Franco, M., Wagner, S., Sassone‐Corsi, P., & Halaban, R. (1995) · PubMed · Cited by 171
Signaling from Ras to Rac and beyond: not just a matter of GEFs
Scita, G., Tenca, P., Frittoli, E., Tocchetti, A., Innocenti, M., Giardina, G., & Di Fiore, P. P. (2000) · The EMBO Journal · doi:10.1093/emboj/19.11.2393 · Cited by 170
Function of the c-Myc oncoprotein in chromatin remodeling and transcription
Amati, B., Frank, S. R., Donjerkovic, D., & Taubert, S. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00020-8 · Cited by 170
Ruben, S. M., Narayanan, R., Klement, J. F., Chen, C. H., & Rosen, C. A. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.2.444 · Cited by 170
Sgouras, D. N., Athanasiou, M. A., Beal, G. J., Fisher, R. J., Blair, D. G., & Mavrothalassitis, G. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00160.x · Cited by 169
Stępczyńska, A., Lauber, K., Engels, I. H., Janßen, O., Kabelitz, D., Wesselborg, S., & Schulze‐Osthoff, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204221 · Cited by 167
v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells.
Frampton, J., Ramqvist, T., & Graf, T. (1996) · Genes & Development · doi:10.1101/gad.10.21.2720 · Cited by 167
McCarthy, S. A., Chen, D., Yang, B.-S., Garcia Ramirez, J. J., Cherwinski, H., Chen, X.-R., Klagsbrun, M., Hauser, C. A., Ostrowski, M. C., & McMahon, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2401 · Cited by 163
Mayer, I. A., Verma, A. K., Grumbach, I. M., Shahab Uddin, M. S., Lekmine, F., Ravandi, F., Majchrzak, B., Fujita, S., Fish, E. N., & Platanias, L. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011685200 · Cited by 162
Induction of Cell Proliferation in Quiescent NIH 3T3 Cells by Oncogenic c-Raf-1
Kerkhoff, E., & Rapp, U. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2576 · Cited by 162
Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential.
Henriksson, M., Bakardjiev, A. I., Klein, G., & Lüscher, B. (1993) · PubMed · Cited by 162
Differentiation of 3T3-L1 Fibroblasts to Adipocytes Induced by Transfection of ras Oncogenes
Benito, M., Porras, A., Nebreda, A. R., & Santos, E. (1991) · Science · doi:10.1126/science.1857988 · Cited by 161
Criqui-Filipe, P., Ducret, C., Maira, S.-M., & Wasylyk, B. (1999) · The EMBO Journal · doi:10.1093/emboj/18.12.3392 · Cited by 160
Pritchard, C. A., Bolin, L., Slattery, R., Murray, R., & McMahon, M. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00548-1 · Cited by 159
Blalock, W., Weinstein-Oppenheimer, C., Chang, F., Hoyle, P., Wang, X.-Y., Algate, P., Franklin, R., Oberhaus, S., Steelman, L., & McCubrey, J. (1999) · Leukemia · doi:10.1038/sj.leu.2401493 · Cited by 158
Self-citationOwa, T., Yoshino, H., Yoshimatsu, K., & Nagasu, T. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013371996 · Cited by 158
Kolbus, A., Herr, I., Schreiber, M., Debatin, K.-M., Wagner, E. F., & Angel, P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.575-582.2000 · Cited by 158
Regulation of Raf by Akt Controls Growth and Differentiation in Vascular Smooth Muscle Cells
Reusch, H. P., Zimmermann, S., Schaefer, M., Paul, M., & Moelling, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105322200 · Cited by 158
Kinases: positive and negative regulators of apoptosis
Franklin, R. A., & McCubrey, J. A. (2000) · Leukemia · doi:10.1038/sj.leu.2401967 · Cited by 158
Self-citationByrd, J. C., Shinn, C. A., Ravi, R. K., Willis, C. R., Waselenko, J. K., Flinn, I. W., Dawson, N. A., & Grever, M. R. (1999) · Blood · doi:10.1182/blood.v94.4.1401 · Cited by 156
Magi-Galluzzi, C., Mishra, R., Fiorentino, M., Montironi, R., Yao, H. W., Capodieci, P., Wishnow, K., Kaplan, I. D., Stork, P. A., & Loda, M. F. (1997) · PubMed · Cited by 155
c‐Myc induces cellular susceptibility to the cytotoxic action of TNF‐alpha.
Klefström, J. T., Västrik, I., SAKSELA, E., Valle, J., Eilers, M., & Alitalo, K. K. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06879.x · Cited by 154
Chiang, C.-W., Harris, G., Ellig, C. L., Masters, S. C., Subramanian, R. R., Shenolikar, S., Wadzinski, B. E., & Yang, E. (2001) · Blood · doi:10.1182/blood.v97.5.1289 · Cited by 154
Proteins of the ETS family with transcriptional repressor activity
Mavrothalassitis, G., & Ghysdael, J. (2000) · Oncogene · doi:10.1038/sj.onc.1204045 · Cited by 153
Myc Potentiates Apoptosis by Stimulating Bax Activity at the Mitochondria
Soucie, E. L., Annis, M. G., Sedivy, J. M., Filmus, J., Leber, B. F., Andrews, D. W., & Penn, L. Z. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.14.4725-4736.2001 · Cited by 150
Nasi, S., Ciarapica, R., Jucker, R., Rosati, J. D., & Soucek, L. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02118-4 · Cited by 149
Ahamed, S., Foster, J. S., Bukovský, A., & Wimalasena, J. (2001) · Molecular Carcinogenesis · doi:10.1002/1098-2744(200102)30:2<88::aid-mc1017>3.0.co;2-e · Cited by 147
Norris, J. L., & Baldwin, A. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13841 · Cited by 147
Lallemand, D., Spyrou, G., Yaniv, M., & Pfarr, C. M. (1997) · Oncogene · doi:10.1038/sj.onc.1200901 · Cited by 147
Matsui, K., Fine, A., Zhu, B., Marshak‐Rothstein, A., & Ju, S. (1998) · PubMed · Cited by 146
Resjö, S., Göransson, O., Härndahl, L., Zołnierowicz, S., Manganiello, V. C., & Degerman, E. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00238-8 · Cited by 144
Regulation of c-myc expression by Ras/Raf signalling
Kerkhoff, E., Houben, R., Löffler, S., Troppmair, J., Lee, J., & Rapp, U. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201520 · Cited by 144
Self-citationMatozaki, T., Nakanishi, H., & Takai, Y. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(00)00102-9 · Cited by 142
Activated Raf-1 causes growth arrest in human small cell lung cancer cells.
Ravi, R. K., Weber, E., McMahon, M., Williams, J. R., Baylin, S. B., Mal, A., Harter, M. L., Dillehay, L. E., Claudio, P. P., Giordano, A., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci831 · Cited by 142
Remacle-Bonnet, M. M., Garrouste, F. L., Heller, S., André, F., Marvaldi, J. L., & Pommier, G. J. (2000) · PubMed · Cited by 141
Morgan, M. A., Dolp, O., & Reuter, C. W. (2001) · Blood · doi:10.1182/blood.v97.6.1823 · Cited by 137
Roy, B., Beamon, J., Bálint, É., & Reisman, D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.7805 · Cited by 135
Hunt, J. T., Ding, C. Z., Batorsky, R. S., Bednarz, M. S., Bhide, R. S., Cho, Y. H., Chong, S., Chao, S. T., Gullo-Brown, J. L., Guo, P., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000248z · Cited by 135
Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene.
Hirakawa, T., & Ruley, H. E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1519 · Cited by 133
Soga, S., Neckers, L. M., Schulte, T. W., Shiotsu, Y., Akasaka, K., Narumi, H., Agatsuma, T., IKUINA, Y., Murakata, C., Tamaoki, T., et al. (1999) · PubMed · Cited by 133
Ras-Induced Activation of Raf-1 Is Dependent on Tyrosine Phosphorylation
Jelı́nek, T., Dent, P., Sturgill, T. W., & Weber, M. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1027 · Cited by 133
Histone deacetylase inhibitors: a new class of potential therapeutic agents for cancer treatment.
Richon, V. M., & O’Brien, J. P. (2002) · PubMed · Cited by 132
Biochemical and biological analysis of Mek1 phosphorylation site mutants.
Huang, W., Kessler, D. S., & Erikson, R. L. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.3.237 · Cited by 131
Wang, Y., & Prywes, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203443 · Cited by 129
Myc-mediated transformation: the repression connection
Claassen, G. F., & Hann, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202747 · Cited by 128
Crespo, N. C., Ohkanda, J., Yen, T. J., Hamilton, A. D., & Sebti, S. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006213200 · Cited by 127
Activation of the Rat Cyclin A Promoter by ATF2 and Jun Family Members and Its Suppression by ATF4
Shimizu, M., Yoriko, N., Suzuki, H., Ichikawa, E., Takeuchi, A., Suzuki, M., Nakamura, T., Nakajima, T., & Oda, K. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3884 · Cited by 124
Control of development and immunity by Rel transcription factors in Drosophila
Govind, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203223 · Cited by 124
Milella, M., Estrov, Z. E., Kornblau, S. M., Carter, B. Z., Konopleva, M. Y., Tari, A. M., Schober, W. D., Harris, D., Leysath, C. E., Lopez‐Berestein, G., et al. (2002) · Blood · doi:10.1182/blood.v99.9.3461 · Cited by 123
Lai, J., Horvath, G., Subleski, J. J., Bruder, J. T., Ghosh, P., & Tan, T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4260 · Cited by 123
Izban, K. F., Ergin, M., Qin, J. Z., Martinez, R. L., RJ, J. R. P., Saeed, S., & Alkan, S. (2000) · Human Pathology · doi:10.1053/hupa.2000.20370 · Cited by 123
Craf-1 protein kinase is essential for mouse development
Wojnowski, L., Stancato, L. F., Zimmer, A. M., Hahn, H., Beck, T. W., Larner, A. C., Rapp, U. R., & Zimmer, A. (1998) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00111-7 · Cited by 121
Lee, B. I., Park, S. H., Kim, J. W., Sausville, E. A., Kim, H. T., Nakanishi, O., Trepel, J. B., & Kim, S. J. (2001) · PubMed · Cited by 120
Wu, X., Noh, S. J., Zhou, G., Dixon, J. E., & Guan, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.3265 · Cited by 119
Trichostatin and Leptomycin: Inhibition of Histone Deacetylation and Signal‐Dependent Nuclear Export
Yoshida, M., & Horinouchi, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09397.x · Cited by 119
Senderowicz, A. M. (2002) · The Oncologist · doi:10.1634/theoncologist.7-suppl_3-12 · Cited by 119
Comparison of potential markers of farnesyltransferase inhibition.
Adjei, A. A., Davis, J. N., Erlichman, C., Svingen, P. A., & Kaufmann, S. H. (2000) · PubMed · Cited by 119
Tolcher, A. W., Reyno, L. M., Venner, P. M., Ernst, S., Moore, M. J., Geary, R. S., Chi, K., Hall, S. R. R., Walsh, W., Dorr, A., et al. (2002) · PubMed · Cited by 119
Bagatell, R., Khan, O., Paine-Murrieta, G. D., Taylor, C. W., Akinaga, S., & Whitesell, L. J. (2001) · PubMed · Cited by 118
Ca2+/Calmodulin-dependent Protein Kinase II Is Required for Microcystin-induced Apoptosis
Fladmark, K. E., Brustugun, O. T., Mellgren, G., Krakstad, C., Bøe, R., Vintermyr, O. K., Schulman, H., & Døskeland, S. O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109049200 · Cited by 117
Gallic, L. L., Sgouras, D. N., Beal, G., & Mavrothalassitis, G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4121 · Cited by 117
Associations of B- and C-Raf with Cholesterol, Phosphatidylserine, and Lipid Second Messengers
Hekman, M., Hamm, H., Villar, A. V., Bader, B., Kuhlmann, J., Nickel, J., & Rapp, U. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200576200 · Cited by 115
Shi, Y., Hsu, J.-H., Hu, L., Gera, J., & Lichtenstein, A. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200043200 · Cited by 114
A novel cAMP-stimulated pathway in protein phosphatase 2A activation.
Feschenko, M., Stevenson, E., Nairn, A., & Sweadner, K. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.111 · Cited by 114
Cioca, D., Aoki, Y., & Kiyosawa, K. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700544 · Cited by 113
Current status of clinical trials of farnesyltransferase inhibitors
Karp, J. E., Kaufmann, S. H., Adjei, A. A., Lancet, J. E., Wright, J. J., & End, D. W. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200111000-00009 · Cited by 112
Huang, H., Reed, C. P., Zhang, J. S., Shridhar, V., Wang, L., & Smith, D. I. (1999) · PubMed · Cited by 110
McCubrey, J. A., Steelman, L., Hoyle, P., Blalock, W. L., Oppenheimer, C. W., Franklin, R. A., Cherwinski, H. M., Bosch, E., & McMahon, M. (1998) · Leukemia · doi:10.1038/sj.leu.2401215 · Cited by 110
Self-citationMarshall, C. J. (1996) · Nature · doi:10.1038/383127a0 · Cited by 109
Ludwig, L., Kessler, H., Wagner, M., Hoang‐Vu, C., Dralle, H., Adler, G., Boehm, B. O., & Schmid, R. M. (2001) · PubMed · Cited by 108
Gelsolin‐induced epithelial cell invasion is dependent on Ras–Rac signaling
Corte, V. D., Bruyneel, E. A., Boucherie, C., Mareel, M., Vandekerckhove, J. S., & Gettemans, J. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf680 · Cited by 107
RhoG Signals in Parallel with Rac1 and Cdc42
Wennerberg, K., Ellerbroek, S. M., Liu, R.-Y., Karnoub, A. E., Burridge, K., & Der, C. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203816200 · Cited by 106
Tamir, A., Howard, J., Higgins, R. R., Li, Y., Berger, L., Zacksenhaus, E., Reis, M. D., & Ben‐David, Y. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4452 · Cited by 106
Piwien‐Pilipuk, G., MacDougald, O. A., & Schwartz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206886200 · Cited by 105
Squires, M. S., NIXON, P. M., & Cook, S. J. (2002) · Biochemical Journal · doi:10.1042/bj20020372 · Cited by 103
Shiotsu, Y., Neckers, L. Μ., Wortman, I. A., An, W. G., Schulte, T. W., Soga, S., Murakata, C., Tamaoki, T., & Akinaga, S. (2000) · Blood · doi:10.1182/blood.v96.6.2284 · Cited by 102
Anti-apoptotic Signaling of Pleiotrophin through Its Receptor, Anaplastic Lymphoma Kinase
Bowden, E. T., Stoica, G. E., & Wellstein, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203963200 · Cited by 102
Li, Y., & Harte, W. E. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023396546 · Cited by 101
Oppenheimer, C. W., Blalock, W. L., Steelman, L. S., Chang, F., & McCubrey, J. A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00085-1 · Cited by 101
Self-citationLoss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model
Adnane, J., Jackson, R. J., Nicosia, S. V., Cantor, A. B., Pledger, W. J., & Sebti, S. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203956 · Cited by 100
Feldkamp, M. M., Lau, N. C., Roncari, L., & Guha, A. (2001) · PubMed · Cited by 100
Sevilla, L., Aperlo, C., Dulić, V., Chambard, J., Boutonnet, C., Pasquier, O., Pognonec, P., & Boulukos, K. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2624 · Cited by 98
Jänicke, R. U., Lee, F., & Porter, A. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.5661-5670.1994 · Cited by 98
Briones, N. J., Malcolm, K. C., Nick, J. A., & Worthen, G. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204455200 · Cited by 97
Nagata, D., Suzuki, E., Nishimatsu, H., Satonaka, H., Goto, A., Omata, M., & Hirata, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005522200 · Cited by 97
Gu, Z., Lee, R. Y., Skaar, T. C., Bouker, K. B., Welch, J. N., Lu, J., Liu, A., Zhu, Y. J., Davis, N., Leonessa, F., et al. (2002) · PubMed · Cited by 97
Dimitroff, C. J., Klohs, W. D., Sharma, A., Pera, P. J., Driscoll, D. L., Veith, J. M., Steinkampf, R. W., Schroeder, M. C., Klutchko, S. R., Sumlin, A. B., et al. (1999) · Investigational New Drugs · doi:10.1023/a:1006367032156 · Cited by 96
Panek, R. L., Lu, G. H., Klutchko, S. R., Batley, B. L., Dahring, T. K., Hamby, J. M., Hallak, H., Doherty, A. M., & Keiser, J. A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37140-x · Cited by 96
Kèlland, L. R., Smith, V., Valenti, M. R., Patterson, L., Clarke, P. A., DETRE, S. I., End, D. W., Howes, A. J., Dowsett, M., Workman, P., et al. (2001) · PubMed · Cited by 96
Signal Transduction–Directed Cancer Treatments
Sausville, E. A., Elsayed, Y. A., Monga, M., & Kim, G. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135813 · Cited by 96
Geijsen, N., Koenderman, L., & Coffer, P. J. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00019-8 · Cited by 94
Fournel, M., Trachy-Bourget, M.-C., Yan, P. T., Kalita, A., Bonfils, C., Beaulieu, C., Fréchette, S., Leit, S. M., Abou-Khalil, E., Woo, S.-H., et al. (2002) · PubMed · Cited by 94
Control of IκBα proteolysis by the ubiquitin-proteasome pathway
Tanaka, K., Kawakami, T., Tateishi, K., Yashiroda, H., & Chiba, T. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01237-8 · Cited by 91
The Raf-1/MEK/ERK Pathway Regulates the Expression of the p21Cip1/Waf1 Gene in Chondrocytes
Beier, F., Taylor, A. C., & Luvalle, P. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30273 · Cited by 90
Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes
Weber, C. K., Slupsky, J. R., Herrmann, C., Schuler, M., Rapp, U. R., & Block, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203261 · Cited by 90
Therapeutic targeting of Src-kinase Lyn in myeloid leukemic cell growth
Roginskaya, V. Y., Zuo, S., Caudell, E. G., Nambudiri, G., Kraker, A. J., & Corey, S. (1999) · Leukemia · doi:10.1038/sj.leu.2401429 · Cited by 90
Ecteinascidin-743 inhibits activated but not constitutive transcription.
Friedman, D., Hu, Z., Kolb, E. A., Gorfajn, B., & Scotto, K. W. (2002) · PubMed · Cited by 89
Hoyle, P., Moye, P. W., Steelman, L., Blalock, W. L., Franklin, R. A., Pearce, M., Cherwinski, H. M., Bosch, E., McMahon, M., & McCubrey, J. A. (2000) · Leukemia · doi:10.1038/sj.leu.2401720 · Cited by 89
Self-citationSwannie, H., & Kaye, S. B. (2002) · Current Oncology Reports · doi:10.1007/s11912-002-0046-7 · Cited by 89
RNA interference may be more potent than antisense RNA in human cancer cell lines
Aoki, Y., Cioca, D., Oidaira, H., et al. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03801.x · Cited by 86
Oncogenes, growth factors and phorbol esters regulate Raf-1 through common mechanisms
Barnard, D., Diaz, B., Clawson, D. K., & Marshall, M. S. (1998) · Oncogene · doi:10.1038/sj.onc.1202061 · Cited by 86
Cheng, J., Wung, B., Chao, Y., & Wang, D. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011317200 · Cited by 85
Duncliffe, K. N., Bert, A. G., Vadas, M. A., & Cockerill, P. N. (1997) · Immunity · doi:10.1016/s1074-7613(00)80424-0 · Cited by 84
Rosário, M., Paterson, H. F., & Marshall, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1270 · Cited by 83
Hoontrakoon, R., Chu, H. W., Gardai, S. J., Wenzel, S. E., McDonald, P. P., Fadok, V. A., Henson, P. M., & Bratton, D. L. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.4.4517 · Cited by 83
Involvement of Myc targets in c-myc and N-myc induced human tumors
Ben‐Yosef, T., Yanuka, O., Halle, D., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201939 · Cited by 83
Chuang, C., & Ng, S. Y. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00480-3 · Cited by 82
Ras-Induced Transformation and Signaling Pathway
Yamamoto, T., Taya, S., & Kaibuchi, K. (1999) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022519 · Cited by 81
Park, S. H., Lee, S. R., Kim, B. C., Cho, E. A., Patel, S. P., Kang, H., Sausville, E. A., Nakanishi, O., Trepel, J. B., Lee, B. I., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106451200 · Cited by 80
New agents in cancer clinical trials
Adams, J., & Elliott, P. J. (2000) · Oncogene · doi:10.1038/sj.onc.1204088 · Cited by 80
Krause, S. W., Neumann, C. R., Soruri, A., Mayer, S., Peters, J. H., & Andreesen, R. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200209000-00006 · Cited by 78
c-Myc Cooperates with Activated Ras To Induce the cdc2 Promoter
Born, T. L., Frost, J. A., Schönthal, A. H., Prendergast, G. C., & Feramisco, J. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.5710 · Cited by 78
Barthomeuf, C., Débiton, E., Mshvildadze, V., Кемертелидзе, Э. П., & Balansard, G. (2002) · Planta Medica · doi:10.1055/s-2002-33807 · Cited by 77
Melotti, P., Nicolis, E., Tamanini, A., Rolfini, R., Pavirani, A., & Cabrini, G. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301533 · Cited by 76
Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system.
Papin, C., DENOUEL, A., Calothy, G., & Eychène, A. (1996) · PubMed · Cited by 76
Pirollo, K. F., Hao, Z., Rait, A. S., Ho, C. W., & Chang, E. H. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.5922 · Cited by 75
Inhibition of c-Jun DNA binding by mitogen-activated protein kinase.
Chou, S. Y., Baichwal, V. R., & Ferrell, J. E. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.10.1117 · Cited by 75
Blalock, W. L., Pearce, M., Steelman, L. S., Franklin, R. A., McCarthy, S. A., Cherwinski, H. M., McMahon, M., & McCubrey, J. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203337 · Cited by 75
Self-citationJohnson, L. N., Moliner, E. D., Brown, N. R., Song, H., Barford, D., Endicott, J., & Noble, M. E. M. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00181-x · Cited by 74
Bosch, E., Cherwinski, H. M., Peterson, D., & McMahon, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201270 · Cited by 74
Boehlk, S., Fessele, S., Mojaat, A., Miyamoto, N. G., Werner, T. B., Nelson, E. L., Schlöndorff, D., & Nelson, P. J. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200004)30:4<1102::aid-immu1102>3.0.co;2-x · Cited by 72
Shao, J., Hartson, S. D., & Matts, R. L. (2002) · Biochemistry · doi:10.1021/bi025737a · Cited by 71
Suppression of apoptosis: role in cell growth and neoplasia
White, M. K., & McCubrey, J. A. (2001) · Leukemia · doi:10.1038/sj.leu.2402143 · Cited by 71
Self-citationPredictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder
Stein, D. J., Montgomery, S., Kasper, S. F., & Tanghøj, P. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200111000-00007 · Cited by 70
Insights into Mechanisms of Cisplatin Resistance and Potential for Its Clinical Reversal
Gosland, M. P., Lum, B. L., Schimmelpfennig, J., Baker, J., & Doukas, M. A. (1996) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1996.tb02913.x · Cited by 68
Peyssonnaux, C., Provot, S., Felder‐Schmittbuhl, M., Calothy, G., & Eychène, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7068-7079.2000 · Cited by 68
Activation of Go-coupled Dopamine D2 Receptors Inhibits ERK1/ERK2 in Pituitary Cells
Liu, J., Baker, R. E., Sun, C., Sundmark, V. C., & Elsholtz, H. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202920200 · Cited by 67
Intracellular Pathways Linking Hypoxia to Activation of c-fos and AP-1
Premkumar, D. R., Adhikary, G., Overholt, J. L., Simonson, M. S., Cherniack, N. S., & Prabhakar, N. R. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46825-5_10 · Cited by 66
Mechanisms of transcriptional activation of cAMP-responsive element-binding protein CREB
Haus‐Seuffert, P., & Meisterernst, M. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4351-0_1 · Cited by 66
Abrogation of c-Raf expression induces apoptosis in tumor cells
Lau, Q. C., Brüsselbach, S., & Müller, R. (1998) · Oncogene · doi:10.1038/sj.onc.1201709 · Cited by 65
Pulverer, B., Hughes, K., Franklin, C. C., Kraft, A. S., Leevers, S. J., & Woodgett, J. R. (1993) · PubMed · Cited by 65
Transcription factors in eukaryotes
Papavassiliou, A. G. (1997) · Landes Bioscience eBooks · Cited by 64
Protein Kinase C Isozymes, Novel Phorbol Ester Receptors and Cancer Chemotherapy
Barry, Ó. P., & Kazanietz, M. G. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397041 · Cited by 63
Cross-talk between signalling pathways and the multidrug resistant protein MDR-1
Ding, S., Chamberlain, M., McLaren, A. W., Goh, L. L., Duncan, I. D., & Wolf, C. R. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2044 · Cited by 63
MAP kinase binds to the NH2‐terminal activation domain of c‐Myc
Gupta, S., & Davis, R. J. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01052-8 · Cited by 63
Muthusamy, N., & Leiden, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22841 · Cited by 63
ERK signalling and oncogene transformation are not impaired in cells lacking A-Raf
Mercer, K., Chiloeches, A., Hüser, M., Kiernan, M., Marais, R., & Pritchard, C. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205101 · Cited by 63
Myc Is an Essential Negative Regulator of Platelet-Derived Growth Factor Beta Receptor Expression
Oster, S. K., Marhin, W. W., Asker, C., Facchini, L. M., Dion, P. A., Funa, K., Post, M., Sedivy, J. M., & Penn, L. Z. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6768-6778.2000 · Cited by 63
Messer, G., Weiss, E. H., & Baeuerle, P. A. (1990) · Cytokine · doi:10.1016/1043-4666(90)90046-v · Cited by 63
Mechanisms of transcriptional activation of cAMP-responsive element-binding protein CREB
Haus‐Seuffert, P., & Meisterernst, M. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007111818628 · Cited by 63
Brown, R. T., Ades, I. Z., & Nordan, R. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31129 · Cited by 62
McCubrey, J. A., Lee, J. T., Steelman, L. S., Blalock, W. L., Moye, P. W., Chang, F., Pearce, M., Shelton, J. G., White, M. K., Franklin, R. A., et al. (2001) · PubMed · Cited by 62
Self-citationVenanzoni, M. C., Robinson, L., Hodge, D. R., Kola, I., & Seth, A. (1996) · PubMed · Cited by 60
Mankiewicz‐Boczek, J., Walter, Z., Tarczyńska, M., Palyvoda, O., Wojtysiak‐Staniaszczyk, M., & Zalewski, M. (2002) · Environmental Toxicology · doi:10.1002/tox.10061 · Cited by 58
An Essential Role for Src Kinase in ErbB Receptor Signaling through the MAPK Pathway
Olayioye, M. A., Badache, A., Daly, J. M., & Hynes, N. E. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5242 · Cited by 57
Inhibition of hypochlorous acid-induced cellular toxicity by nitrite
Whiteman, M., Hooper, D. C., Scott, G. S., Koprowski, H., & Halliwell, B. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152462399 · Cited by 57
Cited by
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Chang, F., Lehmann, B., Terrian, D. M., Milella, M., Tafuri, A., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.10.001 · Cited by 2,284
Self-citationGefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,606
Reactive Oxygen Species-Induced Activation of the MAP Kinase Signaling Pathways
McCubrey, J. A., LaHair, M. M., & Franklin, R. A. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1775 · Cited by 803
Self-citationATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation
Yvan-Charvet, L., Pagler, T., Gautier, E. L., Avagyan, S., Siry, R. L., Han, S., Welch, C. L., Wang, N., Randolph, G. J., Snoeck, H. W., et al. (2010) · Science · doi:10.1126/science.1189731 · Cited by 725
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., & McCubrey, J. A. (2004) · Leukemia · doi:10.1038/sj.leu.2403241 · Cited by 684
Self-citation
Metadata
- Authors
- Chang, F., Steelman, L. S., Lee, J. T., Shelton, J. G., Navolanic, P. M., Blalock, W. L., Franklin, R. A., & McCubrey, J. A.
- Venue
- Leukemia
- Published
- 2003-06-20
- Volume
- 17
- Issue
- 7
- Pages
- 1263-1293
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2075091190
- Cited by
- 725
- References
- 474
- FWCI
- 14.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.